Alto Neuroscience (Alto Neuroscience) Machinery, Furniture, Equipment : $0.59 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Machinery, Furniture, Equipment?

Alto Neuroscience's Machinery, Furniture, Equipment for the quarter that ended in Mar. 2024 was $0.59 Mil.

Alto Neuroscience's quarterly Machinery, Furniture, Equipment increased from Sep. 2023 ($0.57 Mil) to Dec. 2023 ($0.59 Mil) but then stayed the same from Dec. 2023 ($0.59 Mil) to Mar. 2024 ($0.59 Mil).

Alto Neuroscience's annual Machinery, Furniture, Equipment increased from Dec. 2021 ($0.49 Mil) to Dec. 2022 ($0.62 Mil) but then declined from Dec. 2022 ($0.62 Mil) to Dec. 2023 ($0.59 Mil).

Alto Neuroscience Machinery, Furniture, Equipment Historical Data

The historical data trend for Alto Neuroscience's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Machinery, Furniture, Equipment Chart

Alto Neuroscience Annual Data

Trend

Dec21

Dec22

Dec23

Machinery, Furniture, Equipment

0.49

0.62

0.59

Alto Neuroscience Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Machinery, Furniture, Equipment	Get a 7-Day Free Trial			0.62	-	0.57	0.59	0.59

Alto Neuroscience Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

Alto Neuroscience (Alto Neuroscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus

Steven Cohen's Point72 Asset Management Buys New Stake in Alto Neuroscience Inc

By GuruFocus Research • 02-08-2024